First Known Opiate Biomarker Shows Fentanyl’s Effect on Brain

Fentanyl depresses breathing about 4 minutes before symptoms of distress are evident at a dose that is 1700 times lower than that needed for sedation, new research shows. This new information comes after researchers identified a unique EEG signature produced by fentanyl, the first known biomarker of an opiate’s effect on the brain. By monitoring … Read more

The Sixth Sense in Science

Who? What? When? Why? Where? How? The five W’s. I vividly remember being taught to ask these five questions and seeing word-art posted around the classroom when I was a child. As children, we are taught to be curious and ask questions until we understand. We try new food, have new experiences, and explore uncharted … Read more

Why I Left Pharma — After ‘Leaving’ Academia for Pharma

Why don’t we have better psychiatric drugs? After a few years in the pharmaceutical industry, I think I finally understand why. Four years ago, I left full-time academic employment to take full-time research employment at a pharmaceutical company. I wrote a commentary about it for Medscape soon thereafter titled “How Academia Left Me.” Now it’s … Read more

Amazon’s Alexa Is Now a Healthcare Provider

Welcome to the world of high-tech healthcare, where hospitality reigns supreme and the days of pressing buttons and waiting for a response are becoming a thing of the past. Thanks to the emergence of digital personal assistants like Amazon’s popular Alexa device, patients can now simply use their voices to get what they need. In … Read more

Innovative ‘Chatbot’ Reduces Eating Disorder Risk

Engaging with a “chatbot,” a computer program that simulates human conversation, helps prevent eating disorders (EDs) in at-risk individuals, new research suggests. Results of a randomized trial show that at-risk women who interacted with the chatbot showed lower concern about their weight and body shape compared to a wait-list control group. “Chatbots are widely used … Read more